Cargando…
A resource of potential drug targets and strategic decision‐making for obstructive sleep apnoea pharmacotherapy
There is currently no pharmacotherapy for obstructive sleep apnoea (OSA) but there is no principled a priori reason why there should not be one. This review identifies a rational decision‐making strategy with the necessary logical underpinnings that any reasonable approach would be expected to navig...
Autores principales: | Horner, Richard L., Grace, Kevin P., Wellman, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515492/ https://www.ncbi.nlm.nih.gov/pubmed/28544082 http://dx.doi.org/10.1111/resp.13079 |
Ejemplares similares
-
Sex differences in obstructive sleep apnoea
por: Bonsignore, Maria R., et al.
Publicado: (2019) -
Obstructive sleep apnoea in acute coronary syndrome
por: Randerath, Winfried, et al.
Publicado: (2019) -
Non-sleepy obstructive sleep apnoea: to treat or not to treat?
por: Altintas, Nejat, et al.
Publicado: (2019) -
Adipose tissue as a key player in obstructive sleep apnoea
por: Ryan, Silke, et al.
Publicado: (2019) -
Treatment-emergent central sleep apnoea after surgery for obstructive sleep apnoea
por: TESTANI, E., et al.
Publicado: (2018)